Status:
WITHDRAWN
Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension
Lead Sponsor:
Baylor College of Medicine
Conditions:
Tourniquet-induced Pain
Tourniquet-induced Hypertension
Eligibility:
All Genders
18-64 years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of the study is to find out if taking a dose of gabapentin 600 mg by mouth (po) before surgery will help prevent the development of tourniquet pain and hypertension while the tourniquet is...
Eligibility Criteria
Inclusion
- Patient ages 18-64
- ASA physical status 1-3
- Schedule for orif tibia fracture with use of pneumatic tourniquet
Exclusion
- Allergy to study medications
- polytrauma
- lower extremity crush injury
- chronic opioid use
- sickle cell disease or trait
- peripheral vascular disease
- poorly controlled hypertension
- history of DVT/PE
- morbid obesity (BMI \> 35)
- patient or surgeon refusal
- patient inability to properly describe postoperative pain to investigators
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01441531
Start Date
January 1 2012
End Date
June 1 2014
Last Update
March 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ben Taub General Hospital
Houston, Texas, United States, 77030